Close
CEO Mike Nolan
CEO Mike Nolan

Pioneering the most comprehensive multiomics platform for early cancer detection using a routine blood draw.

Timeline

2014

 - Founded

2017

 - Partnered 

Fierce Biotech, Freenome secures $270M to boost its colorectal cancer blood test, expand trial nationwide - August 26, 2020

Freenome
Freenome

CNBC, These start-ups are racing to help doctors detect cancer early with a simple blood test - February 1, 2020

Freenome